相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。B Cells Produce Type 1 IFNs in Response to the TLR9 Agonist CpG-A Conjugated to Cationic Lipids
Munir Akkaya et al.
JOURNAL OF IMMUNOLOGY (2017)
Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems
Prosper N. Boyaka
JOURNAL OF IMMUNOLOGY (2017)
A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice
Mushtaq Ahmed et al.
VACCINE (2017)
Enterovirus 71 infection and vaccines
Eun-Je Yi et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2017)
Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine
Yang Zhou et al.
EXPERT REVIEW OF VACCINES (2016)
The Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine Development
Ping-Chin Chang et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2016)
SCARB2/LIMP-2 Regulates IFN Production of Plasmacytoid Dendritic Cells by Mediating Endosomal Translocation of TLR9 and Nuclear Translocation of IRF7
Hao Guo et al.
JOURNAL OF IMMUNOLOGY (2015)
CpG Oligodeoxynucleotides Facilitate Delivery of Whole Inactivated H9N2 Influenza Virus via Transepithelial Dendrites of Dendritic Cells in Nasal Mucosa
Tao Qin et al.
JOURNAL OF VIROLOGY (2015)
CpG oligodeoxynucleotides as mucosal adjuvants
Sumiko Iho et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Functional Effects of Toll-Like Receptor (TLR)3, 7, 9, RIG-I and MDA-5 Stimulation in Nasal Epithelial Cells
Lotta Tengroth et al.
PLOS ONE (2014)
Receptors for enterovirus 71
Seiya Yamayoshi et al.
EMERGING MICROBES & INFECTIONS (2014)
Human SCARB2 Transgenic Mice as an Infectious Animal Model for Enterovirus 71
Yi-Wen Lin et al.
PLOS ONE (2013)
Protective Efficacy of VP1-Specific Neutralizing Antibody Associated with a Reduction of Viral Load and Pro-Inflammatory Cytokines in Human SCARB2-Transgenic Mice
Hsuen-Wen Chang et al.
PLOS ONE (2013)
Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles
Yu-Li Lin et al.
VACCINE (2012)
Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists
Wenjun Meng et al.
BMC BIOTECHNOLOGY (2011)
The ABC of clinical and experimental adjuvants-A brief overview
Richard Brunner et al.
IMMUNOLOGY LETTERS (2010)
Evolutionary Genetics of Human Enterovirus 71: Origin, Population Dynamics, Natural Selection, and Seasonal Periodicity of the VP1 Gene
Kok Keng Tee et al.
JOURNAL OF VIROLOGY (2010)
Virology, epidemiology, pathogenesis, and control of enterovirus 71
Tom Solomon et al.
LANCET INFECTIOUS DISEASES (2010)
What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?
Igor M. Belyakov et al.
JOURNAL OF IMMUNOLOGY (2009)
Enterovirus 71 infection: a new threat to global public health?
Jane Qiu
LANCET NEUROLOGY (2008)
Expression of VP1 protein in the milk of transgenic mice: A potential oral vaccine protects against enterovirus 71 infection
Hsiao-Ling Chen et al.
VACCINE (2008)
High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture
Chia-Chyi Liu et al.
VACCINE (2007)
Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71
HF Chen et al.
VACCINE (2006)
Mucosal vaccines: the promise and the challenge
MR Neutra et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Immunotherapeutic uses of CpG oligodeoxynucleotides
DM Klinman
NATURE REVIEWS IMMUNOLOGY (2004)
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities
J Vollmer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
C-class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level
M Jurk et al.
IMMUNOBIOLOGY (2004)
Single intranasal mucosal Mycobactetium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis
LH Chen et al.
INFECTION AND IMMUNITY (2004)
Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara
NP Goonetilleke et al.
JOURNAL OF IMMUNOLOGY (2003)
Effective mucosal immunity to anthrax: Neutralizing antibodies and Th cell responses following nasal immunization with protective antigen
PN Boyaka et al.
JOURNAL OF IMMUNOLOGY (2003)
Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus
CN Wu et al.
VACCINE (2001)
Nucleic acid vaccines - Tasks and tactics
BS McKenzie et al.
IMMUNOLOGIC RESEARCH (2001)
分享论文
